Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia

Haematologica

Volumn 88, Issue 12, 2003, Pages 1427-1429

  Wieser, Rotraud ^a   Lechner, Klaus ^a   Valent, Peter ^a   Fonatsch, Christa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

3q26; AML; Deletion; EVI1; Inversion

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CENTROMERE; CHROMOSOME 3Q; DISEASE ASSOCIATION; EVI1 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; LEUKOCYTE COUNT; MONOSOMY 7; PERICENTRIC CHROMOSOME INVERSION; SIGNAL DETECTION; TELOMERE;

BONE MARROW CELLS; CHROMOSOMES, HUMAN, PAIR 3; CLONE CELLS; DNA-BINDING PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; INVERSION, CHROMOSOME; LEUKEMIA; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENES; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 0346102704     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Wieser R. Rearrangements of the long arm of chromosome 3 in myeloid malignancies. Recent Res Devel Biophys Biochem. Vol. 2. Kerala: Research Signpost 2002:113-33.
2. Wieser R, Schreiner U, Pirc-Danoewinata H, Aytekin M, Schmidt H, Rieder H, et al. Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies. Genes Chromosomes Cancer 2001;32:373-80.
3. Wieser R, Schreiner U, Rieder H, Pirc-Danoewinata H, Gruner H, Loncarevic I, et al. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. Haematologica 2003;88:25-30.
4. Soderholm J, Kobayashi H, Mathieu C, Rowley J, Nucifora G. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Leukemia 1997;11:352-8.
5. Horsman D, Gascoyne R, Barnett M. Acute leukemia with structural rearrangements of chromosome 3. Leuk Lymphoma 1995;16:369-77.
6. Reiter E, Greinix H, Rabitsch W, Keil F, Schwarzinger I, Jaeger U, et al. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv(3)(q21q26) or homologous translocation t(3;3)(q21;q26). Ann Hematol 2000;79:374-7.
7. Sinclair P, Nacheva E, Leversha M, Telford N, Chang J, Reid A, et al. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 2000; 95:738-44.
8. Godon C, Proffitt J, Dastugue N, Lafage-Pochitaloff M, Mozziconacci M, Talmant P, et al. Large deletions 5′ to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia. Leukemia 2002;16:1752-4.
9. Osoegawa K, Mammoser A, Wu C, Frengen E, Zeng C, Catanese J, et al. A bacterial artificial chromosome library for sequencing the complete human genome. Genome Res 2001;11:483-96.
10. Paul C, Aly E, Lehman J, Page S, Gomez-Cambronero J, Ackerman S, et al. Human cell line that differentiates to all myeloid lineages and expresses neutrophil secondary granule genes. Exp Hematol 2000;28:1373-80.